Wed 10 Feb 2010 | 7:16 IST
You are here: Home > Money > Quotes > Company News > Article
Home
Money
Business News
Markets
Deals
Economy
Industries
Quotes
Quote
Charts
Profile & Snapshot
Officers & Directors
Key Developments
Company News
Ratios
Financial Statements
Performance
Estimates
Recommendations
Funds
Currencies
Personal Finance
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Newsletters
Partner Services
City SearchNew
About Thomson Reuters

India Sun pharma gets US nod for hypertension drug

Wed Nov 18, 2009 5:00pm IST
 
Email | Print | | Single Page
[-] Text [+]

MUMBAI, Nov 18 (Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.BO: Quote, Profile, Research) said on Wednesday it had approval from the U.S. Food and Drug Administration for Nicardipine Hydrochloride injections, a short-term hypertension treatment.

Nicardipine injections have annual sales of about $170 million in the United States, it said in a statement. (Reporting by Narayanan Somasundaram; Editing by John Mair)

INDIA ECONOMY

Construction workers work at a site as the sun sets in Chandigarh in this December 2006 file photo. REUTERS/Ajay Verma
Economy seen growing at 7.2 pct in FY10 - govt

The forecast reinforces the possibility that the government may start to unwind its fiscal stimulus in the budget.  Full Article 

Food prices seen softening - Ahluwalia
No plan to raise FII limit in debt - official

Market Update

  • IndiaIndia
  • USUS
  • UKUK
  • Asia
  • Most Actives
Greece's Finance Minister Papaconstantinou addresses reporters during a news conference in Athens, January 20, 2010.
Eurozone agreed in principle to aid Greece

Euro zone countries have decided in principle to help debt-stricken Greece, a senior German ruling coalition source said.  Full Article 

FROM THE MARKETS

After the Bell
After the Bell

Reuters Money's Kshitij Anand updates you on the movers and shakers of the Indian stock market.  Blog 

SHOWCASE

"Claw Back" Pay
"Claw Back" Pay

Banks and regulators hope that threats to "claw back" pay if trades later blow up will rein in risk taking on Wall Street.  Full Article 

 
James Saft
Blaming Asperger's

COLUMN - Did Asperger's help cause the financial crisis?  Full Article 

 
Going Global
Going Global

With Volvo, Chinese eye M&A abroad to win at home.  Full Article 

 
Delivery Woes
Delivery Woes

Boeing 787 delivery schedule could slip - experts.  Full Article 

 
Central Banks Cautious
Central Banks Cautious

Reuters tracks the policies of the world's top central banks as the debate over global economic recovery rages on.   Full Coverage